Trials / Conditions / Allogeneic Hematopoietic Cell Transplantation (HCT)
Allogeneic Hematopoietic Cell Transplantation (HCT)
4 registered clinical trials studyying Allogeneic Hematopoietic Cell Transplantation (HCT) — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | MRD-guided Maintenance Post-HCT: Gilteritini vs Sorafenib NCT07463651 | The First Affiliated Hospital of Soochow University | Phase 3 |
| Recruiting | Post-transplantation Maintenance Therapy With Cidabenamide in Patients With Intermediate/High-risk AML NCT07304232 | Institute of Hematology & Blood Diseases Hospital, China | Phase 2 |
| Recruiting | Reduced Intensity Allogeneic HCT in Advanced Hematologic Malignancies w/T-Cell Depleted Graft NCT05088356 | Stanford University | Phase 1 |
| Terminated | Fecal Microbiota Transplantation (FMT) in Recipients After Allogeneic Hematopoietic Cell Transplantation (HCT) NCT03720392 | Zachariah Michael DeFilipp | Phase 2 |